← Back to blog

What Is Peritoneal Mesothelioma and How Do Families Plan for End of Life?

By CRYSTAL BAI

What Is Peritoneal Mesothelioma and How Do Families Plan for End of Life?

The short answer: Peritoneal mesothelioma arises in the lining of the abdomen (peritoneum) and accounts for approximately 20% of all mesothelioma cases. Cytoreductive surgery combined with HIPEC (heated intraperitoneal chemotherapy) offers potential long-term control for select patients; when surgery is not possible, systemic therapy and eventually palliative care become the focus.

Understanding Peritoneal Mesothelioma

Peritoneal mesothelioma affects the peritoneum (abdominal lining) and is associated with asbestos exposure, though the link is less strong than for pleural mesothelioma. Epithelioid histology (most common) has better prognosis than sarcomatoid or biphasic types. Most patients present with abdominal distension, pain, and weight loss.

HIPEC and Cytoreductive Surgery

For eligible patients — good performance status, limited disease, epithelioid histology — cytoreductive surgery (CRS) combined with HIPEC (heated intraperitoneal chemotherapy) is the standard of care and can achieve long-term disease control. Median survival for CRS-HIPEC patients is 40–60 months.

When CRS-HIPEC Is Not Possible

Patients with poor performance status, extensive disease, non-epithelioid histology, or prior failed HIPEC require systemic chemotherapy (gemcitabine + cisplatin, pemetrexed-based) or immunotherapy. Prognosis without surgery is significantly worse — median 6–18 months.

End-of-Life Considerations

Advanced peritoneal mesothelioma causes progressive abdominal distension, bowel obstruction, and pain. Palliative paracentesis (draining abdominal fluid) and symptom management are key comfort measures. Death doulas help families through the often-challenging physical and emotional trajectory of this disease.

Frequently Asked Questions

What is the survival rate for peritoneal mesothelioma?

CRS-HIPEC eligible patients achieve median survival of 40–60 months. Patients treated with systemic therapy alone have median survival of 6–18 months. Individual prognosis depends on histology, extent of disease, and performance status.

Is peritoneal mesothelioma caused by asbestos?

Peritoneal mesothelioma has a weaker association with asbestos than pleural mesothelioma. Some cases have no identifiable asbestos exposure. Other potential risk factors include radiation and genetic predisposition in some families.

Can a death doula help with peritoneal mesothelioma end-of-life planning?

Yes — death doulas support mesothelioma patients and families through advance care planning, legacy work, and emotional support, particularly given mesothelioma's association with occupational exposure and often-strong patient advocacy communities.

What is HIPEC?

HIPEC (hyperthermic intraperitoneal chemotherapy) involves bathing the abdominal cavity with heated chemotherapy during surgery to kill microscopic cancer cells remaining after cytoreductive surgery. It is used for select peritoneal cancers including peritoneal mesothelioma.


Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.